Regen BioPharma, Inc.
RGBP
$0.01
$0.0020.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.60K | 1.80K | 1.80K | 100.00 | 700.00 |
| Total Receivables | 204.90K | 177.10K | 149.70K | 122.30K | 94.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 200.00 | 200.00 | 300.00 | 51.30K | 47.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 274.60K | 179.10K | 151.70K | 173.70K | 143.40K |
|
|
|||||
| Total Current Assets | 274.60K | 179.10K | 151.70K | 173.70K | 143.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 274.60K | 196.80K | 169.50K | 191.40K | 161.10K |
|
|
|||||
| Total Accounts Payable | 1.70K | 30.50K | 33.70K | 36.00K | 29.70K |
| Total Accrued Expenses | 1.84M | 1.77M | 1.75M | 1.71M | 1.66M |
| Short-term Debt | 191.30K | 266.30K | 210.40K | 107.50K | 293.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.01M | 769.90K | 757.30K | 744.60K | 499.90K |
| Total Finance Division Other Current Liabilities | 3.52M | 3.17M | 3.11M | 3.27M | 2.89M |
| Total Other Current Liabilities | 3.52M | 3.17M | 3.11M | 3.27M | 2.89M |
| Total Current Liabilities | 6.56M | 6.01M | 5.87M | 5.87M | 5.38M |
|
|
|||||
| Total Current Liabilities | 6.56M | 6.01M | 5.87M | 5.87M | 5.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 191.30K | 266.30K | 210.40K | 107.50K | 293.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | -- |
| Total Liabilities | 6.56M | 6.01M | 5.87M | 5.87M | 5.38M |
|
|
|||||
| Common Stock & APIC | 15.63M | 15.51M | 15.46M | 15.46M | 15.40M |
| Retained Earnings | -21.69M | -21.12M | -20.95M | -20.93M | -20.42M |
| Treasury Stock & Other | -222.60K | -204.80K | -204.80K | -204.80K | -204.80K |
| Total Common Equity | -6.28M | -5.82M | -5.70M | -5.68M | -5.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | -6.28M | -5.82M | -5.70M | -5.68M | -5.22M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.28M | -5.82M | -5.70M | -5.68M | -5.22M |
|
|
|||||